Search filters

List of works by Sylvain Thepot

Azacitidine in untreated acute myeloid leukemia: a report on 149 patients

scientific article published on 06 February 2014

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

scientific article published on 14 April 2017

Erlotinib antagonizes ABC transporters in acute myeloid leukemia

scientific article

Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia.

scientific article published on 15 September 2011

Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia

scientific article published on 15 July 2011

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

scientific article published on 27 October 2020

Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohort ⬇️

scientific article published on June 21, 2012

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure ⬇️

scientific article published on July 25, 2011

Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.

scientific article published on 06 March 2012

Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.

scientific article published on 16 February 2015

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

scientific article published on 12 October 2010

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

scientific article published on 24 August 2017

The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

scientific article published on 01 December 2012

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).

scientific article published on 27 July 2010

Paulina is supported by:

About Paulina

Help